An interventional study of Digital exercise program and Personal coaching for physical activity promotion in Total Hip Arthroplasty (THA) and Older Adults (65 Years and Older), sponsored by Heidelberg University. Recruiting at 1 site in Germany. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-09-02.
Sponsored by Heidelberg University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 223 studies in Motor Activity with a site in Germany — 41 open to participants now, 48 under way, 1 of them phase 3. Motor Activity · Germany.
Among the 223 studies in Motor Activity with a site in Germany, this one is the 45th largest by planned enrollment of the 193 interventional ones that give a count, is one of 10 that started in 2025, is one of 140 with no phase, reaches primary completion later than 41 of the 47 other live ones, and was the 209th registered.
9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.
Browse Motor Activity studies →41 of the 223 studies in Motor Activity with a site in Germany are open now. Recruiting first, the newest first:
Universität Duisburg-Essen · Sites in Germany
Ages 15+
University of Ulm · Sites in Germany
Ages 18–30 · Healthy volunteers
German Diabetes Center · Sites in Germany
Ages 19–75
Universität Duisburg-Essen · Sites in Germany
Ages 3–18
University Medicine Greifswald · Sites in Germany
Ages 18–64
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
223 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 7 · Phase 2 21 · Phase 3 26 · Phase 4 6
First in 1998; this study’s year is marked. 10 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 213 is above the median of 60 across 8,412 interventional studies indexed under Motor Activity.
Median enrollment 86 across the 193 interventional studies, 147 across the 30 observational. Of the 143 that completed or were terminated, 8 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
20 of 223 have an industry lead sponsor. The 10 most frequent:
Heidelberg University is the lead sponsor of 287 studies on the registry; 18 are open to participants now.
Heidelberg University has 8 studies filed under Motor Activity — fewer than ten, so there is no comparison to draw.
16 of the studies in Motor Activity with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06806059Ludwig-Maximilians - University of MunichPreoperative Physical Activity Before Radical Cystectomy and the Impact on Morbidity | 2026-11-29 |
| NCT06898684Aron OnerupMedulloblastoma Online Video-based Exercise Pilot Study | 2026-12 |
| NCT06768918Zealand University HospitalDigitizing Cancer Rehabilitation During and After Systemic Treatment: Feasibility Testing Implementation in South Baltic Countries | 2026-12-31 |
| NCT06039787University Hospital TuebingenExercise Training on Brain Insulin Responsiveness | 2026-12-31 |
| NCT07237893University of LiegeImpact of a Physical Activity Intervention on Cardiometabolic Health, Mental Health, and Lifestyle Factors. | 2027-01-01 |
Add all 16 to your calendar (.ics) → With an account.
Among the 223 studies in Motor Activity with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to evaluate the efficacy of a 12-week digital home-based intervention program, consisting of a tablet-based exercise program with or without personal coaching, to promote physical activity (PA) in older adults after total hip arthroplasty (THA). The main question it aims to answer is:
Secondary questions are:
Participants' PA will be objectively measured with a body-fixed sensor at 1 week before THA (T1), 6 weeks after THA (T2), and 6 months (i.e. after THA (T3). After the postoperative assessment at T2, participants will be randomly assigned to one of three groups:
Hip osteoarthritis is common in older adults and is associated with limitations in activities of daily living, mobility, and quality of life. THA effectively reduces pain and improves physical functioning. However, patients often show no or only minimal increase in their typically low preoperative PA after THA. This lack of PA improvements may result from short rehabilitation periods, persistent sedentary habits, and methodological limitations of PA monitoring methods that focus mainly on frequency or temporal parameters (e.g. step count, walking or active durations).
Digital home-based training programs offer an opportunity for patients to continue structured exercises independently and at flexible times, extending postoperative care beyond standard rehabilitation. In addition, personal coaching that applies behavioral change techniques (BCTs) such as goal setting, action planning, self-monitoring with feedback, and barrier identification and management, may help break sedentary habits and promote PA. Recent advances in wearable sensor technology and processing algorithms now also enable a more detailed monitoring of real-world digital mobility outcomes (DMOs), allowing also capturing spatial-related parameters (e.g., walking distance, stride length, gait speed).
The iPATH study is a three-armed, assessor-blinded, randomized, parallel-group clinical trial evaluating the efficacy of two 12-week digital home-based intervention programs to promote PA in 213 older adults after THA:
Outcome assessments are conducted at 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3; operationally defined as 26 weeks after THA). Randomization occurs after the T2 assessment, which typically coincides with the end of standard inpatient or outpatient rehabilitation. The digital home-based exercise program in the two intervention arms is based on the Keep-On-Keep-Up (KOKU) app, which includes progressive strength and balance exercises to be performed three times per week. Personal coaching includes three virtual sessions designed to promote PA behavior change using BCTs (goal setting, action planning, self-monitoring and feedback [activity tracker], barrier identification and management). Participants in the control group also receive a tablet but have no access to the KOKU app and do not receive any personal coaching sessions.
The primary outcomes are the mean daily step count (first) and mean daily walking distance (second), derived from a body-fixed sensor attached to the participant's lower back for a maximum measurement period of 7 consecutive days using the newest validated processing alogorithms. Secondary outcomes include additional DMOs (e.g., walking duration, number of walking bouts, walking speed, stride length, cadence), life-space mobility, physical capacity, hip pain and function, psychological and cognitive factors (e.g., concerns about falling, executive functioning), falls, intervention adherence and acceptability, health-related resource use, intervention delivery costs, and safety.
The primary study hypothesis is that the combination of the digital exercise program and personal coaching will lead to higher PA six months after THA compared to usual care. Secondary hypotheses are that (1) the digital exercise program alone will increase PA compared to usual care, and (2) the combination of the digital exercise program and personal coaching will increase PA compared to the digital exercise program alone.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
NYHA class (heart failure)
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive a tablet with the pre-installed training app KOKU, which delivers a 12-week standardized digital home-based strength and balance program. Participants are introduced to KOKU during an initial home visit and are encouraged to complete the program independently over the subsequent 12 weeks. In addition, they receive three individualized coaching sessions via video calls on the tablet during this period. To support self-monitoring and provide feedback on PA behavior - integrated into the BCTs used in the personal coaching - participants also receive a low-cost, easy-to-use wrist-worn activity tracker along with instructions on its use during the initial home visit.
Behavioral: Digital exercise program · Behavioral: Personal coaching for physical activity promotion
Participants receive a tablet with the pre-installed training app KOKU, which delivers a 12-week standardized digital home-based strength and balance program. Participants are introduced to KOKU during an initial home visit and are encouraged to complete the program independently over the subsequent 12 weeks. No personal coaching is provided.
Behavioral: Digital exercise program
Participants receive a tablet without access to the KOKU app and do not receive any personal coaching sessions.
KOKU is a digital adaptation of the evidence based Otago Exercise Program and Falls Management Exercise program, both designed to improve strength, balance, and reduce fall risk in older adults. KOKU includes 26 balance and strength exercises of varying difficulty. Each exercise is accompanied by written and audio instructions for safe performance and is demonstrated by a virtual trainer. Training sessions consist of three exercises suggested by the KOKU app, which participants are encouraged to perform for as many repetitions as possible until fatigue. Progression is guided by the participant's subjective assessment of effort and difficulty. Participants may choose to perform any exercise at any time, regardless of the app-suggested sequence. The KOKU app also provides reminders to exercise if no activity is detected for two days.
Personal coaching consists of three video calls conducted via the study tablet by staff trained in BCTs and motivational communication skills. Participants receive a low cost, wrist worn activity tracker during the initial home visit to support self-monitoring and provide feedback on PA behavior. The first virtual coaching session (week 2) focuses on goal setting and action planning, the second session (week 3) addresses identification and management of barriers, and the third session (week 12) serves as a booster to review and adjust activity goals for the post intervention period.
Daily step count
Mean daily step count \[#/day\] is derived from a body-fixed sensor (AX6, Axivity Ltd.) attached to the participant's lower back for a maximum measurement period of 7 consecutive days, using validated processing algorithms.
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Daily walking distance
Mean daily cumulative walking distance \[m/day\] is derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms.
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Daily walking duration
Mean daily walking duration \[h/day\] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms.
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Daily walking bout count
Mean daily walking bout count \[#/day\] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean daily walking bout count is determined for walking bouts \>10 s, \>30 s, and \>60 s.
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Daily-life walking bout duration
Mean and 90th percentile daily-life walking bout durations \[s\] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms.
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Daily-life walking speed
Mean and 90th percentile daily-life walking speed \[m/s\] are derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean and 90th percentile walking speeds are determined for shorter walking bouts (10-30 s) and for longer walking bouts (\>30 s).
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Daily-life stride length
Mean daily-life stride length \[cm\] is derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean stride length is determined for shorter (10-30 s) and longer (\>30 s) walking bouts.
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Daily-life stride duration
Mean daily-life stride duration \[s\] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean stride duration is determined for all walking bouts and for longer walking bouts (\>30 s).
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Daily-life cadence
Mean and 90th percentile daily-life cadence \[steps/min\] derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum measurement period of 7 consecutive days, based on validated processing algorithms. Mean cadence is determined for all walking bouts and for longer walking bouts (\>30 s), and the 90th percentile cadence for longer walking bouts (\>30 s).
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Daily-life walking variability
Bout-to-bout variability \[%\] in walking bout duration, walking speed and stride length for longer walking bouts (\>30 s), cadence and stride duration for all walking bouts, derived from a body-fixed sensor (AX6, Axivity Ltd.) worn on the participant's lower back over a maximum of 7 consecutive days, based on validated processing algorithms.
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Physical capacity (a)
6-Minute Walk Test (instrumented with the mTEST³ system \[mHealth Technologies srl, Bologna, Italy\] to capture spatio-temporal gait parameters)
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Physical capacity (b)
Timed Up and Go (instrumented with the mTEST³ system \[mHealth Technologies srl, Bologna, Italy\] to measure durations of sit-to-walk, walking, turning, and sitting segments)
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Physical capacity (c)
30-Second Chair Stand Test
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Physical capacity (d)
4-Meter Gait Speed Test
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Hip pain and function
Oxford Hip Score
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Life-space mobility
University of Alabama at Birmingham Life-Space Assessment
Time frame: 1 week preoperatively (T1), and 6 months postoperatively (T3)
Concerns about falling
Short Falls Efficacy Scale-International
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Health-related quality of life
European Quality of Life 5 Dimensions 5 Level index
Time frame: 1 week preoperatively (T1) and 6 months postoperatively (T3)
Self-perceived health status
EuroQol Visual Analogue Scale
Time frame: 1 week preoperatively (T1) and 6 months postoperatively (T3)
Change in self-perceived walking ability
7-point Global Rating of Change Scale (1= markedly worse, 7 = markedly better)
Time frame: 6 weeks postoperatively (T2) and 6 months postoperatively (T3)
Self-reported physical activity level
University of California Los Angeles Activity Score
Time frame: 1 week preoperatively (T1) and 6 months postoperatively (T3)
Conscientiousness
Conscientiousness dimension of Big Five Inventory-2
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Exercise motivation
Behavioural Regulation in Exercise Questionnaire
Time frame: 1 week preoperatively (T1), 6 weeks postoperatively (T2), and 6 months postoperatively (T3)
Rate of falls
Daily fall calendars
Time frame: From 6 weeks postoperatively (T2) to 6 months postoperatively (T3)
Executive functioning
Trail Making Test A \& B
Time frame: 1 week preoperatively (T1) and 6 months postoperatively (T3)
Health-related resource use
Questionnaire for Health-Related Resource Use in an Elderly Population
Time frame: 1 week preoperatively (T1) and 6 months postoperatively (T3)
Adverse events
Frequency, type, severity, and relation to the intervention of participant-reported (serious) adverse adverse events will be documented using standardized case report forms.
Time frame: 6 weeks postoperatively (T2) and 6 months postoperatively (T3); interim events recorded as reported.
Training adherence (a)
Exercise Adherence Rating Scale
Time frame: 6 months postoperatively (T3)
Training adherence (b)
Usage data of the training app (KOKU) retrieved from the tablet
Time frame: 6 months postoperatively (T3)
Intervention acceptability (a)
Theoretical Framework of Acceptability Questionnaire (range: 7-35 points, higher scores indicate higher acceptability)
Time frame: 6 months postoperatively (T3)
Intervention acceptability (b)
5-point Likert scale on global acceptability (1 = completely unacceptable, unacceptable, 5 = completely acceptable)
Time frame: 6 months postoperatively (T3)
Intervention delivery costs
Intervention costs \[€\] derived from personnel, material, and travel expenses, using standardized national unit costs.
Time frame: From the start of the intervention to the end of the intervention (up to 12 weeks)
Plan to share: Yes — In line with the principles of open science, anonymized individual participant data from the iPATH trial will be made available to qualified researchers after the primary evaluation has been completed and published. Data will be shared in a format that does not permit identification of individual participants and in full compliance with applicable data protection regulations (e.g., General Data Protection Regulation, EU data protection standards). Access to the data will be provided via a recognized open-access repository and require a formal application with a description of the proposed research project.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Anonymized individual participant data (IPD) will be made available approximately 6 months after publication of the primary evaluation results and will remain accessible without a predefined end date. The study protocol will be submitted for publication in an open-access, peer-reviewed journal before the last patient is enrolled. The statistical analysis plan (SAP) will be published alongside the primary evaluation results.
Access criteria: Access will be granted to qualified researchers affiliated with recognized academic or research institutions. A formal application including a research proposal is required, and applicants must agree to a data use agreement ensuring ethical use and compliance with EU data protection regulations. Approved applicants will access the data via the designated open-access repository.
Start is estimated for Sep 2025; primary completion for Jan 2028, 28 months later.
Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 28 months is above that.
Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.